RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an 'Outperform' rating for Johnson & Johnson (NYSE:JNJ) and maintained a price target of $175.
September 20, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its 'Outperform' rating for Johnson & Johnson, maintaining a price target of $175. This suggests confidence in JNJ's future performance.
The reiteration of an 'Outperform' rating and a maintained price target of $175 by RBC Capital indicates a positive outlook for Johnson & Johnson. This could lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100